Santen Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
Santen Pharmaceutical has a total shareholder equity of ¥305.4B and total debt of ¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ¥435.7B and ¥130.3B respectively. Santen Pharmaceutical's EBIT is ¥38.5B making its interest coverage ratio 35.3. It has cash and short-term investments of ¥95.0B.
Key information
0%
Debt to equity ratio
JP¥0
Debt
Interest coverage ratio | 35.3x |
Cash | JP¥94.96b |
Equity | JP¥305.37b |
Total liabilities | JP¥130.33b |
Total assets | JP¥435.70b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: SNPH.Y's short term assets (¥236.1B) exceed its short term liabilities (¥92.8B).
Long Term Liabilities: SNPH.Y's short term assets (¥236.1B) exceed its long term liabilities (¥37.5B).
Debt to Equity History and Analysis
Debt Level: SNPH.Y is debt free.
Reducing Debt: SNPH.Y has no debt compared to 5 years ago when its debt to equity ratio was 1.4%.
Debt Coverage: SNPH.Y has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: SNPH.Y has no debt, therefore coverage of interest payments is not a concern.